Navigating cell maps by deep learning integration of single-cell and spatially resolved transcriptomics.

Single-cell RNA sequencing (scRNA-seq) enables genome-wide gene expression profiling at single-cell resolution but loses the spatial context essential for interpreting cell identity and tissue organization. In contrast, spatially resolved transcriptomics (SRT) preserves spatial information but typically lacks single-cell resolution or complete transcriptome coverage. To obtain a more comprehensive view of heterogeneous spatial domains and cellular gene expression, we present Cell2Map, an unsupervised deep learning method that integrates scRNA-seq and SRT data from the same tissue region. Cell2Map assigns individual cells to SRT spots using a graph attention autoencoder equipped with a specially designed multi-term objective function that jointly optimizes expression-based, density-based, and embedding-level similarity and distance constraints. On benchmark datasets from mouse cerebellum and hippocampus, Cell2Map achieves higher single-cell mapping precision and overall accuracy than three popular methods (Celloc, CytoSPACE, Tangram) across a range of noise levels and spot cell densities. In real cancer applications, Cell2Map resolves intratumoral heterogeneity by accurately localizing tumor subclones and separating normal epithelial cells from ductal carcinoma in situ regions, and more faithfully reconstructs tumor microenvironments and immune-cell localization than competing approaches. Across breast cancer and myocardial infarction datasets, Cell2Map consistently attains higher sensitivity with fewer false positives, in close agreement with histological and biological annotations.